Abingdon Health Plc (LON:ABDX – Get Rating) shares hit a new 52-week high on Wednesday . The company traded as high as GBX 15.50 ($0.19) and last traded at GBX 15 ($0.19), with a volume of 834857 shares changing hands. The stock had previously closed at GBX 14.20 ($0.18). Abingdon Health Stock Up 5.6 % […]
Shares of Abingdon Health Plc (LON:ABDX – Get Rating) were up 3.1% on Wednesday . The stock traded as high as GBX 8.50 ($0.11) and last traded at GBX 8.25 ($0.10). Approximately 282,891 shares traded hands during trading, a decline of 16% from the average daily volume of 337,218 shares. The stock had previously closed […]
Share price
10 March 2021 | 14:11pm
StockMarketWire.com - International developer and manufacturer of rapid tests Abingdon Health has signed a non-exclusive sales and distribution agreement in the UK and Europe for the AbC-19 rapid neutralising antibody test with BioSure UK.
Under the terms of the agreement, Abingdon Health and BioSure UK intend to establish a strategic distribution relationship to enable them to identify and maximise opportunities for the sale of the rapid neutralising antibody test in the UK and European territories, prioritising healthcare, workplace and pharmacy settings.
Abingdon Health chief executive Chris Yates said: The nature of SARS-CoV-2 testing is changing. Where antibody tests were once predominantly used for charting the spread of infection within communities, today they are emerging as a key pillar of large-scale immunisation campaigns.
9 March 2021 | 09:21am
StockMarketWire.com - Developer and manufacturer of rapid tests Abingdon Health reported wider first-half losses as higher offset a jump in revenue, driven by COVID-19 tests sales.
For the six months ended 31 December 2020, pre-tax losses widened to £1.571 million from £775,000, while revenue increased to £7.69 million from £1.55 million.
The contract with the DHSC for the supply of COVID-19 rapid antibody test formed a substantial portion of its revenue for the period, the company said. As the business upscales its activities to reach its capacity plans, overhead costs have also increased, predominantly in staff costs (£2.29m) and professional fees (£0.34m), it added.